US Pharmacopeia’s Convention 2005

At its 2005 Convention, USP passed 13 resolutions that will help define the organization’s path for the next five years and represent the interests of its diverse constituency.

Related Content:

Inside StandardsQuality SystemsCompendial CompliancePharmaceutical Technology-04-02-2005

PTC Therapeutics Gains FDA Approval for AADC Deficiency Gene Therapy

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

J&J’s Balversa Gains MHRA Marketing Authorization as Monotherapy for Bladder Cancer